Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
Israel warns Lebanon of 'heavy price' as week's death toll nears 300
Israeli settler fatally shoots Palestinian in West Bank
Israel carries out rare airborne raid in Lebanon; 16 killed in strikes
US skips congressional review to approve arms sale to Israel
Flash floods in Nairobi kill 23, disrupt flights at major airport
